Acute pain following surgery can result from a variety of injuries and should subside after the affected area has fully healed. Analgesics and addressing the underlying cause of the pain are usually effective treatments. Negative effects on the cardiovascular system, the endocrine system, the respiratory system, the metabolic system, etc. can also accompany postoperative pain. Any method used to alleviate postoperative pain should ultimately lead to the patient returning to normal activities as soon as possible. The person can start taking in fluids and food right away, and they can also breathe deeply and cough without worrying about choking. A patient’s risk of cardiac problems, depression, an increased infection rate in the wound, hypoxia and chest infections all increase if postoperative pain is not properly treated. Changes in our understanding of how drugs interact with one another have led to advances in the management of postoperative pain.
To Get More Business Strategies Request for Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/154
It is anticipated that the postoperative pain market will be dominated by the sales of opioids and nonsteroidal anti-inflammatory drugs. Opioids are substances that mimic the effects of morphine by binding to and activating the opioid receptor. As a rule, they are employed for the purpose of relieving main. In order to alleviate discomfort, inflammation, and fever, doctors often prescribe non-steroidal anti-inflammatory drugs.
Global Postoperative Pain Management Market Taxonomy
Based on the product type, the market for postoperative pain management worldwide is classified as follows:
- Non-steroidal anti-inflammatory drugs
- Paracetamol (acetaminophen)
- Ketorolac tromethamine
- Cyclooxygenase-2-selective inhibitors
- Local anesthetics
Based on the type of pain, the market for postoperative pain management worldwide is classified as follows:
- Neuropathic Pain
- Nociceptive Pain
- Visceral Pain
- Somatic Pain
Based on the distribution channel, the market for postoperative pain management worldwide is classified as follows:
- Hospital Pharmacies
- Retail Pharmacies and Drug Store
Prevalent Scenarios in Postoperative Pain Management Market
The global postoperative pain management market is expected to grow at a healthy rate as the number of surgical procedures continues to rise. There were 30,537 surgical procedures in the United States in 2012, according to the World Bank. According to the National Center for Health Statistics, half of all surgical procedures require postoperative pain medication, representing a sizable market for pharmaceutical companies. About 41 million annual visits to the emergency room are attributed to trauma, as reported by the Centers for Disease Control and Prevention (CDC). Each year, doctors must treat about 450,000 cases of burns. The postoperative pain management market as a whole is expected to grow as a result of an uptick in the number of cases involving trauma. Negative reactions to postoperative pain medication are possible with some drugs. Opioids are still widely regarded as the mainstay pain therapy in many settings, despite many advances in postoperative pain management. All opioids have serious adverse effects, which severely restricts their application. Respiratory depression is a common adverse effect of opioid use. As many as 16,500 people died in 2015 from an overdose of prescription opioids, according to the Centers for Disease Control and Prevention. One factor that could slow the growth of the postoperative pain medication market is the rising incidence of drug overdoses and related side effects. Market expansion is anticipated to be driven by the rising elderly population in developing countries and the prevalence of acute diseases in general. The market for painkillers is expected to grow rapidly as a result of rising patient awareness of the need for medical intervention and the expanding body of research into effective pain management. The expansions of public programs that improve postoperative pain management are anticipated to fuel the industry. For instance, in 2008, the Australian government launched the APOP project (Acute postoperative pain management), a nationwide multicenter quality improvement initiative. The purpose of this project was to disseminate the most effective method for dealing with pain after surgery. As a result of rising health spending, improved reimbursement policies, convenient access to sophisticated healthcare treatment, and a rapidly expanding healthcare infrastructure, the North American region is anticipated to contribute a disproportionately large share to the global postoperative pain management market. After North America, Europe is projected to be the second most profitable venture for postoperative pain management.
Get Purchase this Premium Report, click here (Up To 45% Discount) @ https://www.coherentmarketinsights.com/promo/buynow/154
Highly Fragmented Market
Due to the presence of both well-established and up-and-coming competitors, the global postoperative pain management market is extremely splintered. Bayer AG, DURECT Corporation, Pfizer Inc., BTG International Ltd., Novartis AG, and A.P. Pharma, Inc. are just some of the major players in this market.
In order to meet the needs of consumers all over the world, the most important companies in the market employ a wide range of business strategies. For example, in July of 2019, the FDA approved pregabalin capsules manufactured by Alembic Pharmaceuticals in India for the treatment of neuropathic pain.
The major players in the market are using various business strategies, such as getting product permission from regulatory authorities, to increase their global market presence. For example, in July of this year, the FDA approved InvaGen Pharmaceuticals’ (a Cipla Limited subsidiary) generic version of pregabalin capsules. The nerve pain caused by specific diseases can be managed with these pills.
Third, major players in the market are employing various business strategies, such as getting their products approved by regulatory bodies, to give themselves an edge in the global marketplace. For example, RecoveryRX, made by BioElectronics Corporation, was approved by the U.S. Food and Drug Administration (FDA) in August 2019 for the treatment of postoperative pain.
Get customized report as per requirement @ https://www.coherentmarketinsights.com/insight/request-customization/154
Table of Content
Global Postoperative Pain Management Market Research Report
Section 1: Global Postoperative Pain Management Industry Overview
Section 2: Global Economic Impact on Postoperative Pain Management Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Postoperative Pain Management Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Postoperative Pain Management Market Forecast
Check Out More Reports:
U s neuropathic pain treatment market
Duck medicine and vaccines market
Plasma derived medicine market
Acute ischemic stroke therapeutics market
Next generation probiotics market
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame
CA 94010, United States
Phone: U.S.: +1-206-701-6702